BCR-ABL-IN-7
BCR-ABL-IN-7 is a WT and T315I mutant ABL kinase inhibitor.BCR-ABL-IN-7 potently inhibits WT and T315I mutant ABL kinase activity.BCR-ABL-IN-7 can be used in chronic myelogenous leukemia (CML) research.
Product Specifications
CAS Number
688050-42-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
385.41
Molecular Formula
C19H16FN3O3S
Notes
Research use only, not for human use.
Receptor
Bcr-Abl
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
036144-ML490 100 µL
GNL1, ID (GNL1, HSR1, Guanine nucleotide-binding protein-like 1, GTP-binding protein HSR1) (MaxLight 490) discontinued
Ask
View Details 
134661-HRP 100 µL
TRADD (Tumor Necrosis Factor Receptor Type 1-associated DEATH Domain Protein, TNFR1-associated DEATH Domain Protein, TNFRSF1A-associated Via Death Domain) (HRP)
Ask
View Details 
